3Kliem V, Johnson RJ, Alpers CE, et al. Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-ncphrcctomized rats. Kidney Int, 2001,49:666 - 678.
4McGregor B, Colon S, Mutin M, et al. Thrombospondin in human glomerulopathies. A marker of inflammation and early fibrosis. Am J Pathol, 1994, 144(6) :1281 - 1287.
5Johnsen SA, Subramaniam M, et al.TGFbeta inducible early gene enhances TGFbeta/Smad-dependent transcriptional responses. Oncogene, 2002, 21 (37):5783-5790.
7Jinde K, Nikolic-Paterson DJ, et al. Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am J Kidney Dis,2001,38:761 -769.
8Weigert C, Sauer U, Brodbeck K, et al. AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-beta1 promoter in mesangial cells. J Am Soc Nephrol, 2000, 11 (11 ) :2007 -2016.
9Poczatek MH, Hugo C, Darley-Usmar V,et al. Glucose stimulation of transforming growth factor-beta bioactivity in mesangial cells is mediated by thrombospondin-1. Am J Pathol, 2000, 157 ( 4 ) : 1353 - 1363.
10Daniel C, Wiede J, Krutzsch HC,et al. Thrombospondin-1 is a major activator of TGF-beta in fibrotic renal disease in the rat in vivo. Kidney Int, 2004, 65(2) :459 -468.
